Effect of the supplement on associative memory in cognitively intact older adults - A randomized, double-blind, placebo-controlled, parallel-group clinical trial-

Effect of the supplement on associative memory in cognitively intact older adults - A randomized, double-blind, placebo-controlled, parallel-group clinical trial- - Enhancement effect of the supplement containing ginkgo biloba extract on associative memory and brain activation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034059

Enrollment

Registered

2018-09-07

Start date

2018-09-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitively intact older adults

Interventions

Test food (Administration period: 180days) Control food (Administration period: 180days)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Males and females 60 to 74 years of age 2. Right handed

Exclusion criteria

Exclusion criteria: 1.Smoker 2.Who is using the heart pacemaker 3.Who has records of any of the below:autonomic nervous system disease (autonomic imbalance, Meniere syndrome), brain disease, depression, bipolar depression and mood disorder 4.Who is taking medicine, Chinese medicine or supplements for brain function or brain blood flow improvement. 5.Who has dermatosis on head. 6.Who has records of any of the below:cerebral hemorrhage, subarachnoid hemorrhage, cardiac hypertrophy, cardiac decompensation, ischemic heart disease, nephrosclerosis, Aortic dissection, brain infarction. 7.Who had brain damage and hospitalized or had an operation within the past 10 years. 8.High blood pressure, hyperlipidemia, diabetes, hepatopathy, kidney disease, malignant tumor. 9.Who is participating other study.

Design outcomes

Primary

Measure	Time frame
-Hemoglobin oxygenation state in the brain -Behavioral data (accuracy, error rate, response time)	—

Secondary

Measure	Time frame
-Attentional task score (1) -Attentional task score (2) -Questionnaire score	—

Countries

Japan

Contacts

Public ContactKao YAMAOKA

FANCL Corporation Research Institute

kao1512@fancl.co.jp045-820-3965

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026